ADRIANA HUNG

Summary

Affiliation: Vanderbilt University
Country: USA

Publications

  1. doi Novel dialysis modalities: do we need new metrics to optimize treatment?
    Rachel Fissell
    Glickman Urological Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA
    J Clin Pharmacol 52:72S-8S. 2012
  2. doi Administration of IL-1ra improves adiponectin levels in chronic hemodialysis patients
    Adriana M Hung
    Clinical Science Research and Development Veterans Administration, TVHS, Nashville, TN, USA
    J Nephrol 27:681-8. 2014
  3. pmc Comparative Effectiveness of Second-Line Agents for the Treatment of Diabetes Type 2 in Preventing Kidney Function Decline
    Adriana M Hung
    Health Services Research and Development Center, Veterans Health Administration Tennessee Valley Healthcare System Geriatric Research Education Clinical Center, Nashville, Tennessee
    Clin J Am Soc Nephrol 11:2177-2185. 2016
  4. doi Dialysate and serum potassium in hemodialysis
    Adriana M Hung
    Veterans Administration Tennessee Valley Healthcare System, Nashville, TN Vanderbilt University Medical Center, Nashville, TN Electronic address
    Am J Kidney Dis 66:125-32. 2015
  5. pmc Comparative effectiveness of incident oral antidiabetic drugs on kidney function
    Adriana M Hung
    VA Tennessee Valley, Clinical Science Research and Development, Geriatric Research Education Clinical Center GRECC, Department of Medicine, Nashville, TN, USA
    Kidney Int 81:698-706. 2012
  6. pmc CRP polymorphisms and progression of chronic kidney disease in African Americans
    Adriana M Hung
    Vanderbilt University Medical Center, 1161 21st Avenue South and Garland, Division of Nephrology, S 3223 MCN, Nashville, TN 37232 2372, USA
    Clin J Am Soc Nephrol 5:24-33. 2010
  7. pmc CRP polymorphisms and chronic kidney disease in the third national health and nutrition examination survey
    Adriana M Hung
    Veterans Administration Tennessee Valley Healthcare System Nashville, TN, USA
    BMC Med Genet 12:65. 2011
  8. doi Determinants of C-reactive protein in chronic hemodialysis patients: relevance of dialysis catheter utilization
    ADRIANA HUNG
    Veterans Administration Tennessee Valley Healthcare System, Clinical Research Center of Excellence and Geriatric Research Education Clinical Center, Nashville, Tennessee, USA
    Hemodial Int 12:236-43. 2008

Detail Information

Publications8

  1. doi Novel dialysis modalities: do we need new metrics to optimize treatment?
    Rachel Fissell
    Glickman Urological Kidney Institute, Cleveland Clinic, Cleveland, Ohio, USA
    J Clin Pharmacol 52:72S-8S. 2012
    ....
  2. doi Administration of IL-1ra improves adiponectin levels in chronic hemodialysis patients
    Adriana M Hung
    Clinical Science Research and Development Veterans Administration, TVHS, Nashville, TN, USA
    J Nephrol 27:681-8. 2014
    ..We evaluated whether short-term administration of interleukin 1 receptor antagonist (IL-1ra) improves adiponectin levels and insulin sensitivity in MHD patients...
  3. pmc Comparative Effectiveness of Second-Line Agents for the Treatment of Diabetes Type 2 in Preventing Kidney Function Decline
    Adriana M Hung
    Health Services Research and Development Center, Veterans Health Administration Tennessee Valley Healthcare System Geriatric Research Education Clinical Center, Nashville, Tennessee
    Clin J Am Soc Nephrol 11:2177-2185. 2016
    ..Glucose control improves kidney outcomes. Most patients eventually require treatment intensification with second-line medications; however, the differential effects of those therapies on kidney function are unknown...
  4. doi Dialysate and serum potassium in hemodialysis
    Adriana M Hung
    Veterans Administration Tennessee Valley Healthcare System, Nashville, TN Vanderbilt University Medical Center, Nashville, TN Electronic address
    Am J Kidney Dis 66:125-32. 2015
    ....
  5. pmc Comparative effectiveness of incident oral antidiabetic drugs on kidney function
    Adriana M Hung
    VA Tennessee Valley, Clinical Science Research and Development, Geriatric Research Education Clinical Center GRECC, Department of Medicine, Nashville, TN, USA
    Kidney Int 81:698-706. 2012
    ..The risk associated with rosiglitazone was similar to metformin for both outcomes. Thus, compared to metformin, oral antidiabetic drug treatment with sulfonylureas increased the risk of a decline in eGFR, ESRD, or death...
  6. pmc CRP polymorphisms and progression of chronic kidney disease in African Americans
    Adriana M Hung
    Vanderbilt University Medical Center, 1161 21st Avenue South and Garland, Division of Nephrology, S 3223 MCN, Nashville, TN 37232 2372, USA
    Clin J Am Soc Nephrol 5:24-33. 2010
    ..It is unknown if CRP polymorphisms are associated with CKD progression or modify the effectiveness of anti-hypertensive therapy in delaying CKD progression...
  7. pmc CRP polymorphisms and chronic kidney disease in the third national health and nutrition examination survey
    Adriana M Hung
    Veterans Administration Tennessee Valley Healthcare System Nashville, TN, USA
    BMC Med Genet 12:65. 2011
    ..We recently reported an association between the gene variant rs2808630 and CKD progression in African Americans with hypertensive kidney disease. This association has not been studied in other ethnic groups...
  8. doi Determinants of C-reactive protein in chronic hemodialysis patients: relevance of dialysis catheter utilization
    ADRIANA HUNG
    Veterans Administration Tennessee Valley Healthcare System, Clinical Research Center of Excellence and Geriatric Research Education Clinical Center, Nashville, Tennessee, USA
    Hemodial Int 12:236-43. 2008
    ..009). Our results indicate that the presence of a hemodialysis catheter is an independent determinant of an exaggerated inflammatory response in CHD patients representing a potentially modifiable risk factor...

Research Grants1

  1. Inflammation, proteolysis and IL-1beta receptor inhibition in CHD patients
    ADRIANA HUNG; Fiscal Year: 2008
    ..We want to test if reducing inflammation with an anti-inflammatory treatment will reduce muscle loss in dialysis patients. [unreadable] [unreadable] [unreadable]..